Author

Marc Remke

Saarland UniversityORCID 0000-0002-9404-9993Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 6 Assay:bulk RNA-seq· 4 Research Focus:differential expression· 4 Approach:statistical model· 4 Research Focus:cell type annotation· 3 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:clustering· 1

Frequent Co-Authors

Daniel J. PicardiD· 3 shared Daniel Picard· 2 shared David KoppsteiniD· 2 shared Guido ReifenbergeriD· 2 shared Nan QiniD· 2 shared Stefan Michael PfisteriD· 2 shared Vithusan Suppiyar· 2 shared Volker HovestadtiD· 2 shared

Activity by Year

2021-2026 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Daniel J. PicardORCID

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

CCR2 is a potential biomarker and therapeutic target in Group 3 medulloblastoma

Carlos Custodia, Rita Cascão, Eunice Paisana, Daniel Picard, Pedro Ruivo, Tiago Rodrigues, Inês Lourenço, Sofia Nunes, Nan Qin, Luisa Albuquerque, Rafael Roque, José Miguéns, Marc Remke, Joao T. Barata, Claudia C Faria

This study identifies CCR2 as a biomarker and therapeutic target in Group 3 medulloblastoma, showing its association with dissemination and poor survival, and demonstrating therapeutic efficacy through Cenicriviroc.

bioRxiv · Oct 13, 2026 · PreprintCancer Biology

R-CHOP in B cell non-Hodgkin lymphoma: balancing anti-tumor efficacy and NK-cell functionality

Johanna Jansky, Hannah Breitung, Sylvia Zöphel, Laetitia Döngi, Florian Wentzel, Daniel J. Picard, Nadja Küchler, Hermann Eichler, Marc Remke, Moritz Bewarder, Lorenz Thurner, Gebhard Stopper, Eva C. Schwarz, Markus Hoth

This study evaluates the impact of R-CHOP chemotherapy on NK cell viability and function in DLBCL cell lines and patients, finding that treatment reduces NK cell numbers but preserves their cytotoxicity.

bioRxiv · Jul 23, 2026 · PreprintCancer Biology

GALE-dependent glycoproteome remodelling is a determinant of oncogenic RAS transformation

Frauke Stölting, Rita Vesce, César Rodríguez-Santana, Marina Ciscar, Alberto Delaidelli, Qiaochu Lin, Christian Ballmeyer, Sophie Chan, Ramona Lesch, Ruitong Li, Abhimanyu DasGupta, Bin Yu, Daniel Picard, Vithusan Suppiyar, Francesco Casini, , Jonathan K. M. Lim

This study identifies GALE as a key regulator of glycoproteome remodelling in RAS-driven cancer, showing its role in sialylation and tumorigenicity.

bioRxiv · Jun 23, 2026 · PreprintCancer Biology

hTERT Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma

Ryuma Tanaka, Banlanjo Abdulaziz Umaru, Matthew Sobo, Shiva Senthil Kumar, Kathleen McCarthy O'Toole Dorris, Volker Hovestadt, Vijay Ramaswamy, Marc Remke, Ashley Margol, Charles B. Stevenson, Shahab Asgharzadeh, Stewart Goldman, Lili Miles, Jie Huang, Katja von Hoff, , Rachid Drissi

This study examines hTERT expression and its prognostic impact in pediatric medulloblastoma, finding higher expression correlates with worse survival outcomes.

bioRxiv · May 6, 2026 · PreprintCancer Biology

Linker histone H1-0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape

Vera Helena Jepsen, Andrea Hänel, Daniel J. Picard, Rigveda Bhave, Rebecca Hasselmann, Juha Mehtonen, Julian Schliehe‐Diecks, Carla‐Johanna Kath, Vithusan Suppiyar, Yash Prasad, Katerina Schaal, Jia‐Wey Tu, Nadine Rüchel, Ersen Kameri, Nan Qin, , Ute Fischer

This study identifies H1-0 as a mediator of ETV6::RUNX1-induced quiescence in BCP-ALL preleukemic cells and suggests HDACi treatment as a potential therapeutic approach.

HemaSphere · Apr 1, 2025Peer-reviewedCancer Biology

Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion

Christina Blume, Helin Dogan, Lisa Schweizer, Matthieu Peyre, Sophia Doll, Daniel J. Picard, Roman Sankowski, Volker Hovestadt, Konstantin Okonechnikov, Philipp Sievers, Areeba Patel, David Reuss, Mirco Friedrich, Damian Stichel, Daniel Schrimpf, , Felix Sahm

This study integrates phospho-proteogenomic and single-cell transcriptomic data to subtype meningiomas and identify subtype-specific immune infiltration patterns.

bioRxiv · May 11, 2021 · PreprintGenomics